Is There Room for Immune Checkpoint Inhibitors in Patients Who Have NSCLC With Autoimmune Diseases?

被引:6
|
作者
Remon, Jordi [1 ]
Hendriks, Lizza [2 ]
Aspeslagh, Sandrine [3 ]
Besse, Benjamin [4 ,5 ]
机构
[1] HM Delfos, Ctr Integral Oncol Clara Campal Barcelona, Med Oncol Dept, Barcelona, Spain
[2] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Pulm Dis Dept, Maastricht, Netherlands
[3] UZ Brussels VUB, Dept Med Oncol, Brussels, Belgium
[4] Gustave Roussy, Dept Canc Med, Villejuif, France
[5] Univ Paris Saclay, Orsay, France
关键词
LUNG-CANCER; EFFICACY; SAFETY;
D O I
10.1016/j.jtho.2019.07.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1701 / 1703
页数:3
相关论文
共 50 条
  • [1] Autoimmune Skin Diseases and Immune Checkpoint Inhibitors
    Fattore, Davide
    Potestio, Luca
    Genco, Lucia
    Pages, Cecile
    Ortiz, Ariadna
    Fabbrocini, Gabriella
    Sibaud, Vincent
    CRITICAL REVIEWS IN IMMUNOLOGY, 2022, 42 (03) : 11 - 22
  • [2] Immune checkpoint inhibitors for patients with pre-existing autoimmune diseases
    Maeda, Osamu
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2023, 85 (01) : 33 - 34
  • [3] Immune Checkpoint Inhibitors in NSCLC
    Johnson, Douglas B.
    Rioth, Matthew J.
    Horn, Leora
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (04) : 658 - 669
  • [4] Immune Checkpoint Inhibitors in NSCLC
    Douglas B. Johnson
    Matthew J. Rioth
    Leora Horn
    Current Treatment Options in Oncology, 2014, 15 : 658 - 669
  • [5] IMMUNE CHECKPOINT INHIBITORS: FAIL TO KEEP A CHECK ON AUTOIMMUNE DISEASES
    Desai, D.
    Khandwala, P.
    Tan, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 447 - 448
  • [6] Toxicities of single agent and combination immune checkpoint inhibitors in patients with autoimmune diseases.
    Cytryn, Samuel
    Efuni, Elizaveta
    Sandigursky, Sabina
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Safety and Clinical Outcomes of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Diseases
    Yeung, Cynthia
    Kartolo, Adi
    Holstead, Ryan
    Moffat, Gordon T.
    Hanna, Lilian
    Hopman, Wilma
    Lakoff, Joshua
    Baetz, Tara
    JOURNAL OF IMMUNOTHERAPY, 2021, 44 (09) : 362 - 370
  • [8] OUTCOMES IN PATIENTS WITH PRE-EXISTING AUTOIMMUNE DISEASES WHO RECEIVED IMMUNE CHECKPOINT INHIBITORS: A REAL-WORLD STUDY
    Pavlick, Anna
    Palaia, Jennell
    Pisupati, Radhika
    Fu, Benjamin
    Wittstock, Keith
    Zhang, Ying
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A461 - A461
  • [9] Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a Fluke
    Lorenzo Belluomini
    Francesco Fiorica
    Antonio Frassoldati
    Oncology and Therapy, 2019, 7 : 83 - 91
  • [10] Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a Fluke
    Belluomini, Lorenzo
    Fiorica, Francesco
    Frassoldati, Antonio
    ONCOLOGY AND THERAPY, 2019, 7 (01) : 83 - 91